Enjoy complimentary customisation on priority with our Enterprise License!
The global cell surface markers market size is estimated to grow by USD 14.07 billion at a CAGR of 8.25% between 2023 and 2028. The surge in precision medicine drives market growth analysis, tailoring treatments based on genetics and lifestyle. Cell surface markers, pivotal in personalized medicine, aid in disease prognosis and treatment selection. Innovations like single-cell analysis amplify their importance, with tools such as PCR arrays crucial for market forecasting. A trend in market research and growth is the rising popularity of flow cytometry, favored for its multiparametric analysis in In Vitro Diagnostics, research, and drug discovery. This technique's accuracy in identifying cell surface markers aids in addressing viral infections and bacterial infections, crucial for treatment efficacy. With its ability to detect signaling heterogeneity and organelle targets, the global market forecast anticipates expansion, fueled by ongoing funding and demand for flow cytometers, reagents and kits, and benchtop instruments for precise analysis and maintenance.
For More Highlights About this Report, Download Free Sample in a Minute
The market share growth by the disease diagnosis segment will be significant during the forecast period. Analysis of cell surface markers using immunophenotyping allows for effective disease identification, sample preparation, drug discovery, disease diagnosis, and determination of further treatment. The growing adoption of in-vitro diagnostics is also expected to drive market growth. In-vitro diagnostics (IVD) includes diagnostic test products, instruments, and supplies.
Get a glance at the market contribution of various segments Download the PDF Sample
The disease diagnosis segment was valued at USD 15.57 billion in 2018. IVD is focused on easily and quickly identifying painful conditions outside the body. The high incidence of chronic diseases, such as cancer and cardiovascular disease, as well as the increased need to shorten the time to diagnose diseases, has led to an increase in the demand for IVDs. Thus, the need for accurate and early disease detection and the rising demand for precision medicines are expected to fuel the growth of the global market through the disease diagnosis segment during the forecast period.
For more insights on the market share of various regions Download PDF Sample now!
North America is estimated to contribute 39% to the growth of the global market during the forecast period. Technavio’s analysts have elaborately explained the regional trends and drivers that shape the market during the forecast period.
North America holds the largest share in the market due to the expanding applications in disease diagnosis, well-established research institutions, and robust R&D in the biotechnology industry. The US dominates the North American market, fueled by high healthcare spending, rapid technology adoption, and a focus on precise diagnostics. The demand for CAR T-cell therapy is expected to rise with the increasing number of cancer cases in the US.
For instance, the American Cancer Society projects 1,958,310 new cancer cases in 2023. The presence of numerous biotechnology companies in the US, coupled with strategic initiatives and product launches, contributes to the strong demand for cell-surface markers, as seen with Bio-Rad Laboratories' introduction of StarBright Dyes for flow cytometry in November 2020. Such initiatives are poised to drive growth in the regional market during the forecast period.
The market is experiencing significant growth, driven by the increasing demand for precision medicine and advancements in life sciences research. A notable trend in this market is the increasing popularity of the flow cytometry technique, which enables efficient analysis for various applications such as cancer research, stem cell research, and neurobiology research.
However, despite these drivers and trends, challenges persist, particularly the technical complexity associated with cell surface markers. Developing reliable antibodies and accurately identifying T cell, B cell, NK cell, and monocyte cell surface markers require sophisticated techniques and specialized expertise. Overcoming these challenges is crucial for advancing research applications, clinical applications, and drug discovery & development in the biotechnology industry. Government initiatives and increased R&D activities are essential in addressing these challenges and fostering innovation in personalized medicine.
Increasing demand for precision medicine is a key factor driving the market growth. Precision medicine, also known as personalized medicine, tailors medical treatment based on individual factors like genetics and lifestyle. Cell surface markers play a key role in this approach by providing insights into cell expression patterns.
Researchers use these markers to identify biomarkers associated with diseases and treatment responses, enabling predictions of disease progression and personalized treatment selection. This targeted approach improves treatment efficiency and minimizes side effects, particularly in oncology, where cell-surface markers identify tumor antigens for specific therapies. Advancements like single-cell analysis enhance the role of cell surface markers, making tools like PCR arrays, which analyze multiple markers simultaneously, crucial for the growing demand in precision medicine, thereby driving the global market growth.
The increasing popularity of flow cytometry technique is a key trend shaping the cell surface makers market. Flow cytometry, a robust analytical tool, efficiently identifies cell surface markers, gaining popularity in research, diagnostics, and drug discovery due to its versatility. A key driver is its multiparametric analysis capability, simultaneously measuring numerous cell-surface markers in thousands of cells at high speed. This multiplexing enhances efficiency and cost-effectiveness, providing detailed information about the populations.
Flow cytometry's sensitivity and resolution detect rare cell populations and subtle marker expression differences, making it valuable in fields like immunology. Its accuracy and precision make it a preferred choice, and as research and diagnostic needs grow, the global market is expected to expand, driven by continued flow cytometry adoption for precise analysis.
Technical complexity associated with cell-surface markers is a key challenge hindering the market growth. A key challenge in the global market is the technical complexity in their analysis. Sophisticated techniques like flow cytometry demand costly equipment, reagents, and skilled personnel, acting as entry barriers, particularly in smaller settings. Moreover, handling vast multidimensional data from these techniques requires advanced bioinformatic tools and expertise in data analysis, posing potential bottlenecks in research and clinical workflows. This technical complexity may hinder the widespread adoption of these during the forecast period.
Companies are implementing various strategies, such as strategic alliances, partnerships, mergers and acquisitions, geographical expansion, and product/service launches, to enhance their presence in the market.
Abcam plc: The company offers cell-surface markers such as Human immune cell markers and Mouse immune cell markers.
The research report also includes detailed analyses of the competitive landscape of the market and information about 15 market companies, including:
Qualitative and quantitative analysis of companies has been conducted to help clients understand the wider business environment as well as the strengths and weaknesses of key market players. Data is qualitatively analyzed to categorize companies as pure play, category-focused, industry-focused, and diversified; it is quantitatively analyzed to categorize companies as dominant, leading, strong, tentative, and weak.
In the realm of life sciences research, the market plays a pivotal role, especially given the global prevalence of cancer and the increasing focus on stem cell research and neurobiology research. Antibodies serve as indispensable tools in studying cell-surface markers, often utilized in studies involving mice, rats, and various other models. T cell surface markers, B cell surface markers, NK cell surface markers, and monocyte cell surface markers are crucial for both research applications and clinical applications, driving R&D activities and drug discovery & development efforts within the pharmaceutical industry.
Government initiatives and collaborations fuel advancements in understanding host-pathogen interactions (HPI), particularly concerning viral, bacterial, and parasitic infections, as well as inflammatory diseases. High-content screening and the emergence of new technologies, such as acoustic focusing flow cytometry technology, enhance our ability to assess disease severity and immune responses. Flow cytometry assays, hematology analyzers, and imaging-enhanced flow cytometry are vital tools in cell therapy applications, ensuring the quality of cells analyzed. With imaging flow cytometry and machine learning algorithms, real-time identification and classification of cells become feasible, aligning with government protocols and research activities.
In this dynamic landscape, regulatory bodies like the U.S. Food and Drug Administration (FDA) play a crucial role in overseeing in vitro diagnostic techniques such as complete blood count and erythrocyte sedimentation rate measurements, ensuring patient data safety and adherence to quality control standards. As key developments unfold, the market continues to evolve, driving advancements in both research and clinical domains. Medical research and drug development are intricate processes that rely heavily on understanding cell surface antigens and differentiation (CD) markers. These markers, which are proteins or molecules found on the outer surface of cells, serve as identification tags that help researchers characterize and distinguish different cell types.
In the field of Life Sciences Solutions, advancements in technology have enabled scientists to delve deeper into the intricacies of cell surface antigens and CD markers. Through innovative techniques and methodologies, researchers can identify and study these markers with unprecedented precision, shedding light on their roles in health and disease. The National Institutes of Health (NIH) plays a pivotal role in advancing medical research and drug development by funding and conducting groundbreaking studies in this area. By supporting research initiatives focused on understanding cell surface antigens and differentiation markers, the NIH contributes to the development of novel therapeutic interventions and diagnostic tools that have the potential to improve patient outcomes and quality of life.
Market Scope |
|
Report Coverage |
Details |
Page number |
166 |
Base year |
2023 |
Historic period |
2018 - 2022 |
Forecast period |
2024-2028 |
Growth momentum & CAGR |
Accelerate at a CAGR of 8.25% |
Market growth 2024-2028 |
USD 14.07 billion |
Market structure |
Fragmented |
YoY growth 2023-2024(%) |
7.83 |
Regional analysis |
North America, Europe, Asia, and Rest of World (ROW) |
Performing market contribution |
North America at 39% |
Key countries |
US, Germany, France, UK, and China |
Competitive landscape |
Leading Companies, Market Positioning of Companies, Competitive Strategies, and Industry Risks |
Key companies profiled |
Abbott Laboratories, Abcam plc, Agilent Technologies Inc., Becton Dickinson and Co., Bio Rad Laboratories Inc., Bio Techne Corp., Cell Signaling Technology Inc., Danaher Corp., DiaSorin SpA, F. Hoffmann La Roche Ltd., GenScript Biotech Corp., Grifols SA, IVD Medical Holding Ltd., Johnson and Johnson, PerkinElmer Inc., QIAGEN NV, Siemens Healthineers AG, Sysmex Corp., Thermo Fisher Scientific Inc., and Werfenlife SA |
Market dynamics |
Parent market report analysis, Market growth inducers and obstacles, Fast-growing and slow-growing segment analysis, COVID 19 impact and recovery analysis and future consumer dynamics, Market condition analysis for forecast period |
Customization purview |
If our report has not included the data that you are looking for, you can reach out to our analysts and get segments customized. |
We can help! Our analysts can customize this market research report to meet your requirements.
1 Executive Summary
2 Market Landscape
3 Market Sizing
4 Historic Market Size
5 Five Forces Analysis
6 Market Segmentation by Application
7 Market Segmentation by Product
8 Customer Landscape
9 Geographic Landscape
10 Drivers, Challenges, and Trends
11 Vendor Landscape
12 Vendor Analysis
13 Appendix
Get lifetime access to our
Technavio Insights
Cookie Policy
The Site uses cookies to record users' preferences in relation to the functionality of accessibility. We, our Affiliates, and our Vendors may store and access cookies on a device, and process personal data including unique identifiers sent by a device, to personalise content, tailor, and report on advertising and to analyse our traffic. By clicking “I’m fine with this”, you are allowing the use of these cookies. Please refer to the help guide of your browser for further information on cookies, including how to disable them. Review our Privacy & Cookie Notice.